Mapping the Way: Opportunities in Diagnostics

In an era of health reform, diagnostic technologies that focus on prevention and test the viability of expensive treatment options are becoming increasingly valuable to health providers, payers, and patients. Historically, investment in this sector has not seen the vigor demonstrated with medical devices or biotech innovations. However, in today’s environment, diagnostics are becoming attractive opportunities for companies looking for collaborations or acquisitions as well as investors looking for cutting-edge technologies, all creating a robust industry on the brink of breaking through to the mainstream.

In this presentation, panelists will:

• Provide insight on the diagnostic industry on a local and national level
  
• Discuss key elements that are reviewed when assessing start-up opportunities
  
• Discuss where opportunities exist for maximizing profits
  
• Provide new strategies for raising funds in this dynamic marketplace

Panelist:

• 
  
  Ronald S. Eppen, Partner, Foley & Lardner LLP
  
  
• 
  
  Lucy Lu, Vice President of Business Development, Crescendo Bioscience
  
  
• 
  
  Natasha Paul, Ph.D., Scientific Investigator, TriLink Biotechnologies, Inc.
  
  
• 
  
  Jon Vance, Director, Avondale Partners, LLC